BIIB vs FVR · P/E 21, rev $9.89B vs rev $67.1M
Biogen Inc (BIIB) versus FrontView REIT, Inc. (FVR) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
FrontView REIT, Inc. (FVR) is a reit - diversified company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported FVR revenue for 2025-12-31 was $67.1M. Net income was -$3.8M. Revenue was up 342.2% from 2024-12-31 to 2025-12-31. FVR currently screens at market cap $281.0M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. FVR currently screens at market cap $281.0M.
Not investment advice. Open the BIIB and FVR stock pages for the full models.
Not investment advice.